Literature DB >> 11052855

Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland.

S Capewell1, B M Livingston, K MacIntyre, J W Chalmers, J Boyd, A Finlayson, A Redpath, J P Pell, C J Evans, J J McMurray.   

Abstract

OBJECTIVES: To analyse short- and long-term case-fatality trends following admission to hospital with a first acute myocardial infarction, in men and women between 1986 and 1995, after adjusting for risk factors known to influence survival.
DESIGN: A Scottish-wide retrospective cohort study.
SETTING: The Linked Scottish Morbidity Record Database was analysed. This contains accurate data on all hospital admissions since 1981, for the Scottish population of 5.1 million. It is linked to the Registrar General's death certificate data.
SUBJECTS: All 117 718 patients admitted to Scottish hospitals with a principal diagnosis of first acute myocardial infarction (ICD-9 code 410) between 1986 and 1995. MAIN OUTCOME MEASURES: The outcome was death, both in and out of hospital, from any cause, at 30 days, 1 year, 5 and 10 years.
RESULTS: Overall case-fatality following hospital admission with acute myocardial infarction was 22. 2%, 31.4%, 51.1% and 64.0% at 1 month, 1 year, 5 and 10 years, respectively. Multivariate analyses identified statistically significant independent prognostic factors. Thirty day mortality increased twofold for each decade of increasing age, and increased with any prior admission to hospital. When comparing the most deprived category to that of the most affluent, men had a 10% increased mortality (P<0.01), whilst women had an increased mortality of 4% (not significant). After adjustment for age, sex, deprivation and prior admission to hospital, case-fatality rates fell significantly between 1986 and 1995. Short-term case-fatality fell by 46% in men (27% in women) and long-term by 34% in men (30% in women) (both P<0.001).
CONCLUSIONS: Population-based case-fatality rates in Scotland have fallen dramatically since 1986, particularly in men. The increasing survival in patients admitted to hospital suggests that the trial-based efficacy of modern therapies is now translating into population-based effectiveness. However, an individual's life expectancy still halves after a diagnosis of acute myocardial infarction. Of the variables that we could examine, age was the most powerful predictor of prognosis. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2000        PMID: 11052855     DOI: 10.1053/euhj.2000.2318

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  38 in total

1.  Trends in five-year survival of patients discharged after acute myocardial infarction.

Authors:  Iqbal R Bata; Ronald D Gregor; Hermann K Wolf; Brenda Brownell
Journal:  Can J Cardiol       Date:  2006-04       Impact factor: 5.223

2.  Primary angioplasty should be first line treatment for acute myocardial infarction: AGAINST.

Authors:  Kevin S Channer
Journal:  BMJ       Date:  2004-05-22

3.  Costs and benefits of free medications after myocardial infarction.

Authors:  Irfan A Dhalla; Monique A Smith; Niteesh K Choudhry; Avram E Denburg
Journal:  Healthc Policy       Date:  2009-11

4.  Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002.

Authors:  P Buch; S Rasmussen; G H Gislason; J N Rasmussen; L Køber; N Gadsbøll; S Stender; M Madsen; C Torp-Pedersen; S Z Abildstrom
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

5.  Heart failure and the aging population: an increasing burden in the 21st century?

Authors:  S Stewart; K MacIntyre; S Capewell; J J V McMurray
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

6.  Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.

Authors:  I Gemmell; R F Heller; K Payne; R Edwards; M Roland; P Durrington
Journal:  Qual Saf Health Care       Date:  2006-10

7.  Cost effectiveness of intensive lipid-lowering treatment for patients with congestive heart failure and coronary heart disease in the US.

Authors:  Virginia M Rosen; Douglas C A Taylor; Hemangi Parekh; Ankur Pandya; David Thompson; Andreas Kuznik; David D Waters; Michael Drummond; Milton C Weinstein
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000.

Authors:  Luigi Palmieri; Kathleen Bennett; Simona Giampaoli; Simon Capewell
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

9.  Increasing socioeconomic inequalities in first acute myocardial infarction in Scotland, 1990-92 and 2000-02.

Authors:  Carolyn A Davies; Ruth Dundas; Alastair H Leyland
Journal:  BMC Public Health       Date:  2009-05-11       Impact factor: 3.295

10.  Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005.

Authors:  Tom Briffa; S Hickling; M Knuiman; M Hobbs; J Hung; F M Sanfilippo; K Jamrozik; P L Thompson
Journal:  BMJ       Date:  2009-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.